INNP
PARTIAL INVALIDATION PROCESSED BY THE IB
11/07/2025
Back to search
Official data from USPTO
LUNAPHORE
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
LUNAPHORE
ST13
US500000079179383Class
5, 9, 10
Filing
79179383
Registration
5361858
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
71
Latest update
11/08/2025
Trademark type
Word
Nice classes
5, 9, 10
Filing date
11/06/2015
Registration date
12/26/2017
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
09/18/2024
Last transaction
11/08/2025
Responsible office
United States Patent and Trademark Office
Status code
706
Official register
Principal Register
Drawing code
4
Owner type
99
Owner location
Tolochenaz, CH
Examiner
HENRY,NAKIA D
Current location
Historical data usage
Holders and representatives
Holders
Lunaphore Technologies SA
Lunaphore Technologies SA
Representatives
Courtney Thompson Fredrikson & Byron, P.A.
Technical classification
Nice Classes
Class 5Class 9Class 10
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
Diagnostic substancespreparations and agents for medical purposes; diagnostic reagents and contrast media for medical purposes; contrast media for use with medical equipment; diagnostic biomarker reagents for medical purposes; biological and chemical reagents for medical purposes; diagnostic test reagents for medical purposes; medical diagnostic reagents and assays for testing of body fluids ; biotechnological preparations for medical purposes for the treatment of cancer and metabolic diseases
Class 9
Scientific apparatus and instrumentselectronic analyzers for testing and analyzing chemical and biological substances for the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms; optical apparatus and instrumentsmicroscopesoptical profilersoptical filtersoptical glassesoptical lens sightsoptical scannersoptical readersoptical reflectors; weighing apparatus and instrumentsscales and balances; measuring apparatus and instrumentsinstruments for measuring the quantity of contaminantspollutantsmalignant cells in humananimalplantmicroorganism cells and tissues; signaling apparatus and instrumentssignal processorssignal splitters for electronic apparatus; measuring and testing machines and instrumentsdigitizers; laboratory apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; microfluidic testing apparatus not for medical purposes in the form of assay chipsbiological assay chipssample processing chips; microfluidic systemssample processing and reagent distribution devices in the nature of rigid plates made of glass and silicon and flexible and stretchable plates made of polymer that include a set of miniaturized fluidic channels and tubesreservoirspumps and microsensors for the study and analysis of chemical and biological samples; apparatus for diagnosis by microfluidicsnot for medical purposes used to diagnose cancer; chipsintegrated circuits; microfluidic chips in the nature of integrated circuits; DNA chips; biochips for research or scientific purposes; microchips; microfluidic microchips; micro lab-on-chipsmicrochips; microprocessors; microfluidic microprocessors; measurement sensors other than for medical use used to measure biomarker expression levels in samples; apparatusinstruments and devicescalculating machinescentral processing units and computers for the inputoutputtransmissionstorageprocessing of datain particular scientific and medical data; Software for use by geneticists and specialists in the bio-medical field featuring scientific and medical data recordings relating to the presenceabsencequantity of malignant cells or tumors in humansanimalsplantsmicroorganisms collected via immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; bioinformatics software; software for diagnosis and analysis by microfluidics and by immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing
Class 10
Medical apparatus and instruments for use in immunohistochemistryin-situ hybridizationimmunofluorescenceimmunocytochemistryimmunocytofluorescencein-situ sequencing; medical apparatus and instruments for diagnostic useapparatus for medical diagnostic testing in the fields of cancer or other tissue-based diagnostic testingcytology and cell-based testing using fluid technology; diagnostic apparatus for medical purpose; microfluidic testing apparatus for medical purposes for testing biomarker expression levels in cell and tissue samples
Publications
History of USPTO decisions and trademark events.
71 publications found
INPS
PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
09/21/2025
INPC
INVALIDATION PROCESSED
09/20/2025
RNWL
INTERNATIONAL REGISTRATION RENEWED
06/05/2025
INPR
PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
05/18/2025
NA71
NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED
09/18/2024
71AG
REGISTERED-SEC.71 ACCEPTED
09/18/2024
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
09/16/2024
ES71
TEAS SECTION 71 RECEIVED
12/22/2023
NREP
NEW REPRESENTATIVE AT IB RECEIVED
11/10/2023
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
10/06/2023
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
10/06/2023
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
10/06/2023
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
10/06/2023
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
10/06/2023
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
10/06/2023
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/26/2022
CHAN
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
07/05/2022
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
07/05/2022
ECDR
TEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS
07/05/2022
EWAF
TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
07/05/2022
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
07/05/2022
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
07/05/2022
COAR
TEAS CHANGE OF OWNER ADDRESS RECEIVED
07/05/2022
ADCH
CHANGE OF NAME/ADDRESS REC'D FROM IB
11/27/2020
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
05/19/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/02/2018
FIMP
FINAL DISPOSITION PROCESSED
04/02/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/26/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
12/26/2017
GPNX
NOTIFICATION PROCESSED BY IB
11/17/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/10/2017
PUBO
PUBLISHED FOR OPPOSITION
10/10/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/20/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/20/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/20/2017
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
09/05/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
08/16/2017
XAEC
EXAMINER'S AMENDMENT ENTERED
08/15/2017
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
08/15/2017
GNEA
EXAMINERS AMENDMENT E-MAILED
08/15/2017
CNEA
EXAMINERS AMENDMENT -WRITTEN
08/15/2017
OPNX
NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
07/08/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
06/21/2017
OPNR
NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
06/21/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
04/14/2017
GNFR
FINAL REFUSAL E-MAILED
04/14/2017
CNFR
FINAL REFUSAL WRITTEN
04/14/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/24/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/24/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
03/20/2017
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
09/26/2016
GNRT
NON-FINAL ACTION E-MAILED
09/26/2016
CNRT
NON-FINAL ACTION WRITTEN
09/26/2016
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
09/26/2016
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/26/2016
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/02/2016
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/02/2016
ALIE
ASSIGNED TO LIE
09/02/2016
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
08/29/2016
CREV
CORRECTION FROM IB ENTERED - ATTORNEY REVIEW REQUIRED
08/18/2016
RFNT
REFUSAL PROCESSED BY IB
03/26/2016
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/08/2016
RFRR
REFUSAL PROCESSED BY MPU
03/08/2016
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
03/05/2016
CNRT
NON-FINAL ACTION WRITTEN
03/04/2016
DOCK
ASSIGNED TO EXAMINER
03/01/2016
CRCV
CORRECTION TRANSACTION RECEIVED FROM IB
01/22/2016
MAFR
APPLICATION FILING RECEIPT MAILED
01/05/2016
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
12/31/2015
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
12/30/2015
Continuous trademark protection
Get notified about every new filing that threatens LUNAPHORE or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.